Your session is about to expire
← Back to Search
Soft Contact Lenses
Twelve Month Clinical Evaluation of KeraSoft IC Soft Contact Lenses
N/A
Waitlist Available
Research Sponsored by Bausch & Lomb Incorporated
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 visits over 1 year
Awards & highlights
No Placebo-Only Group
Summary
The objective of this twelve month dispensing study is to evaluate the clinical performance, particularly comfort and vision, of KeraSoft IC Soft Contact Lenses.
Eligible Conditions
- Keratoconus
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 visits over 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 visits over 1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Comfort
Secondary study objectives
Visual Acuity - High Contrast
Visual Acuity - Low Contrast
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: KeraSoft IC Soft Contact LensesExperimental Treatment1 Intervention
KeraSoft IC Soft Contact Lenses, with CIBA Clear Care solution provided for lens care
Find a Location
Who is running the clinical trial?
Bausch & Lomb IncorporatedLead Sponsor
257 Previous Clinical Trials
58,234 Total Patients Enrolled
2 Trials studying Keratoconus
53 Patients Enrolled for Keratoconus
Robert Steffen, OD, MSStudy DirectorBausch & Lomb Incorporated
5 Previous Clinical Trials
323 Total Patients Enrolled